Publication | Open Access
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)
11
Citations
17
References
2023
Year
URL: https://www.clinicaltrials.gov; Unique Identifier: NCT04467905.
| Year | Citations | |
|---|---|---|
Page 1
Page 1